Wang, K.; Xiu, M.; Su, X.; Wu, F.; Zhang, X.
Association between Changes in Total Antioxidant Levels and Clinical Symptom Improvement in Patients with Antipsychotic-Naïve First-Episode Schizophrenia after 3 Months of Risperidone Monotherapy. Antioxidants 2022, 11, 646.
https://doi.org/10.3390/antiox11040646
AMA Style
Wang K, Xiu M, Su X, Wu F, Zhang X.
Association between Changes in Total Antioxidant Levels and Clinical Symptom Improvement in Patients with Antipsychotic-Naïve First-Episode Schizophrenia after 3 Months of Risperidone Monotherapy. Antioxidants. 2022; 11(4):646.
https://doi.org/10.3390/antiox11040646
Chicago/Turabian Style
Wang, Keqiang, Meihong Xiu, Xiuru Su, Fengchun Wu, and Xiangyang Zhang.
2022. "Association between Changes in Total Antioxidant Levels and Clinical Symptom Improvement in Patients with Antipsychotic-Naïve First-Episode Schizophrenia after 3 Months of Risperidone Monotherapy" Antioxidants 11, no. 4: 646.
https://doi.org/10.3390/antiox11040646
APA Style
Wang, K., Xiu, M., Su, X., Wu, F., & Zhang, X.
(2022). Association between Changes in Total Antioxidant Levels and Clinical Symptom Improvement in Patients with Antipsychotic-Naïve First-Episode Schizophrenia after 3 Months of Risperidone Monotherapy. Antioxidants, 11(4), 646.
https://doi.org/10.3390/antiox11040646
